Inventor · disambiguated record
Mario Contorni
Also filed as: CONTORNI MARIO
20 granted patents·25 pending applications·289 citations·filing 2002–2024
95Inventor score
Files withCONTORNI MARIO16GLAXOSMITHKLINE BIOLOGICALS SA10NOVARTIS AG8NOVARTIS VACCINES & DIAGNOSTIC5SEQIRUS UK LTD3
Top patents by PatentIndex Score
45 records- 0196US8834888B2Adjuvanting meningococcal factor H binding proteinNOVARTIS AG·Filed 2013·Granted Sep 16, 2014·37 cites·34 claims
- 0296US8398988B2Adjuvanting meningococcal factor H binding proteinCONTORNI MARIO·Filed 2012·Granted Mar 19, 2013·64 cites·5 claims
- 0395US7348006B2Vaccines comprising aluminium adjuvants and histidineNOVARTIS VACCINES & DIAGNOSTIC·Filed 2002·Granted Mar 25, 2008·105 cites·30 claims
- 0491US10568953B2Adjuvanting meningococcal factor H binding proteinGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2019·Granted Feb 25, 2020·6 cites·20 claims
- 0591US8802111B2Manufacture of vaccines that contain both hepatitis B virus surface antigens and surfactantCONTORNI MARIO·Filed 2011·Granted Aug 12, 2014·7 cites·36 claims
- 0688US10149901B2Influenza vaccines with reduced amounts of squaleneSEQIRUS UK LTD·Filed 2016·Granted Dec 11, 2018·3 cites·24 claims
- 0788US9511132B2Mixing lyophilised meningococcal vaccines with D-T-Pa vaccinesCONTORNI MARIO·Filed 2009·Granted Dec 6, 2016·5 cites·43 claims
- 0887US10195264B2Immunising against meningococcal serogroup Y using proteinsCONTORNI MARIO·Filed 2005·Granted Feb 5, 2019·11 cites·15 claims
- 0986US7754218B2Vaccines comprising aluminum adjuvants and histidineNOVARTIS CACCINES AND DIAGNOST·Filed 2008·Granted Jul 13, 2010·15 cites·53 claims
- 1085US11246921B2Influenza vaccines with reduced amounts of squaleneSEQIRUS UK LTD·Filed 2019·Granted Feb 15, 2022·1 cites·20 claims
- 1185US9180204B2Liquid vaccines for multiple meningococcal serogroupsNOVARTIS AG·Filed 2014·Granted Nov 10, 2015·6 cites·26 claims
- 1285US8883166B2Combination vaccines with whole cell pertussis antigenCONTORNI MARIO·Filed 2006·Granted Nov 11, 2014·9 cites·21 claims
- 1384US8765135B2Liquid vaccines for multiple meningococcal serogroupsCONTORNI MARIO·Filed 2004·Granted Jul 1, 2014·17 cites·15 claims
- 1478US10245311B2Adjuvanting meningococcal factor H binding proteinGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2017·Granted Apr 2, 2019·1 cites·2 claims
- 1575US9278126B2Influenza vaccines with reduced amounts of squaleneCONTORNI MARIO·Filed 2010·Granted Mar 8, 2016·2 cites·21 claims
- 1671US2025049906A1Immunogenic compositionsGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2024·Application pending·0 cites
- 1770US2015174234A1Influenza vaccines with reduced amount of emulsion adjuvantNOVARTIS VACCINES & DIAGNOSTIC·Filed 2014·Application pending·0 cites
- 1867US12128094B2Immunogenic compositions comprising OMVs, an acellular pertussis antigen, a tetanus toxoid and a diphtheria toxoidGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2019·Granted Oct 29, 2024·0 cites·19 claims
- 1967US9572884B2Adjuvanting meningococcal factor H binding proteinNOVARTIS AG·Filed 2014·Granted Feb 21, 2017·0 cites·27 claims
- 2067US2009155305A1Manufacture of Vaccines That Contain Both Hepatitis B Virus Surface Antigen and SurfactantCONTORNI MARIO·Filed 2006·Application pending·0 cites
- 2167US2009304742A1Influenza vaccines with reduced amount of emulsion adjuvantNOVARTIS VACCINES & DIAGNOSTIC·Filed 2006·Application pending·0 cites
- 2265US2020138927A1Non-cross-linked acellular pertussis antigens for use in combination vaccinesGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2019·Application pending·0 cites
- 2364US2011311576A1Mixing lyophilised meningococcal vaccines with non-hib vaccinesCONTORNI MARIO·Filed 2009·Application pending·0 cites
- 2463US2014302087A1Manufacture of vaccines that contain both hepatitis b virus surface antigen and surfactantNOVARTIS VACCINES & DIAGNOSTIC·Filed 2014·Application pending·0 cites
- 2561US2017119868A1Adjuvanting meningococcal factor h binding proteinGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2016·Application pending·0 cites
- 2660US9855324B2Immunogenic compositionsGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2013·Granted Jan 2, 2018·0 cites·15 claims
- 2760US9259460B2Combination vaccines with low dose of Hib conjugateCONTORNI MARIO·Filed 2011·Granted Feb 16, 2016·0 cites·23 claims
- 2860US2015273036A1Non-cross-linked acellular pertussis antigens for use in combination vaccinesGLAXOSMITHKLINE BIOLOG SA·Filed 2013·Application pending·0 cites
- 2958US2010285069A1Meningococcal vaccine formulationsCONTORNI MARIO·Filed 2008·Application pending·0 cites
- 3058US2009285854A1Frozen stockpiling of influenza vaccinesNOVARTIS AG·Filed 2007·Application pending·0 cites
- 3158US2009208526A1Combination vaccines with low dose of hib conjugateCONTORNI MARIO·Filed 2005·Application pending·0 cites
- 3257US2012121714A1Compositions with antigens adsorbed to calcium phosphateCONTORNI MARIO·Filed 2012·Application pending·0 cites
- 3356US2019134186A1Influenza vaccines with reduced amount of emulsion adjuvantSEQIRUS UK LTD·Filed 2018·Application pending·0 cites
- 3454USRE45587EVaccines comprising aluminum adjuvants and histidineCONTORNI MARIO·Filed 2012·Granted Jun 30, 2015·0 cites·107 claims
- 3554US2009035326A1Compositions with antigens adsorbed to calcium phosphateNOVARTIS AG·Filed 2006·Application pending·0 cites
- 3654US2018036402A1Immunogenic compositionsGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2017·Application pending·0 cites
- 3754US2012070458A1Adjuvanting meningococcal factor h binding proteinCONTORNI MARIO·Filed 2010·Application pending·0 cites
- 3850US2013273091A1Immunogenic compositionsBERTI FRANCESCO·Filed 2011·Application pending·0 cites
- 3950US2010226937A1Combination vaccines with 1-hydroxy-2-phenoxyethane preservativeNOVARTIS AG·Filed 2007·Application pending·0 cites
- 4050US2024148849A1Immunogenic composition, use and methodsGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2022·Application pending·0 cites
- 4149US2010203137A1Formulation of meningitis vaccinesCONTORNI MARIO·Filed 2008·Application pending·0 cites
- 4246US2015283232A1Immunogenic compositionsNOVARTIS AG·Filed 2015·Application pending·0 cites
- 4345US2009220547A1Reducing interference between oil-containing adjuvants and surfactant-containing antigensNOVARTIS VACCINES & DIAGNOSTIC·Filed 2006·Application pending·0 cites
- 4443US2016228529A1Meningococcal vaccine formulationsGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2016·Application pending·0 cites
- 4536US2015044251A1Stable compositions for immunising against staphylococcus aureusNOVARTIS AG·Filed 2012·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Mario Contorni files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →